Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

Publisher: Elsevier BV

ISSN (Electronic): 1474-547X

ISSN (Print): 0140-6736

Publication date (Electronic): Aug 03 2019

Volume: 394

Issue: 10196

Affiliations

[1 ] Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Beijing Institute of Respiratory Medicine, Beijing, China.

[2 ] Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.

[3 ] Department of Pulmonary and Critical Care Medicine, Shanxi Dayi Hospital, Taiyuan, China.

[4 ] Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

[5 ] Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

[6 ] Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

[7 ] Department of Pulmonary and Critical Care Medicine, First Hospital of China Medical University, Shenyang, China.

[8 ] State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

[9 ] Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.

[10 ] State Key Laboratory of Biotherapy of China and Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.

[11 ] Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.

[12 ] Department of Respiratory and Critical Care Medicine, Beijing Hospital, Beijing, China; National Center of Gerontology, Beijing Hospital, Beijing, China.

[13 ] Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.

[14 ] Institute of Clinical Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.

[15 ] Institute of Clinical Medical Sciences, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China.

[16 ] School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

[17 ] Department of Pulmonary and Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang, China.

[18 ] National Center of Gerontology, Beijing Hospital, Beijing, China.

[19 ] Center for Clinical Epidemiology and Evidence-based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

[20 ] Tobacco Medicine and Tobacco Cessation Center, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.

[21 ] Department of Stomatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

[22 ] Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

[23 ] Department of Epidemiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Beijing Institute of Respiratory Medicine, Beijing, China.

[24 ] Department of Respiratory and Critical Care Medicine, Beijing Hospital, Beijing, China.

[25 ] National Heart and Lung Institute, Imperial College London and Royal Brompton and Harefield NHS Trust, London, UK.

[26 ] Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.

[27 ] Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: cyh-birm@263.net.

Article

Publisher Item ID: S0140-6736(19)31147-X

DOI: 10.1016/S0140-6736(19)31147-X

PubMed ID: 31230828

SO-VID: 6aa118b6-4ff0-4a05-b978-db34744aa5d7

History

Data availability:

Comments

Comment on this article

scite_

Cited by 219

See all cited by

- Version 1